PPARG and metabolic syndrome: For example, the study carried out by Choi et al. demonstrated that PTMs of PPARγ regulate PPARγ activity or stability, thereby optimizing PPARγ activity and reducing insulin resistance [141], which could improve the treatment of metabolic syndromes and atherosclerotic vascular diseases.